Integrative Transcriptomic-Histological Analysis in Dilated Cardiomyopathy Unveils FGFR1 Inhibition as Anti-Cardiac Fibrotic and Cardioprotective Therapy

Visual Abstract

• Publication year

  2025

• Venue

  JACC: Basic to Translational Science

• Publication date

  2025-09-10

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.jacbts.2025.101363PMID 40934809PMCID 12665400
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Comprehensive analysis of scRNA-seq and bulk RNA-seq reveals the non-cardiomyocytes heterogeneity and novel cell populations in dilated cardiomyopathy

  2025cited by this paper
• Single-Cell RNA Sequencing Reveals Cardiac Fibroblast-Specific Transcriptomic Changes in Dilated Cardiomyopathy

  2024cited by this paper
• Modeling cardiac fibroblast heterogeneity from human pluripotent stem cell-derived epicardial cells

  2023cited by this paper
• An international multi-institutional validation study of the algorithm for prostate cancer detection and Gleason grading

  2023cited by this paper
• Association between MMP2 gene polymorphisms and dilated cardiomyopathy in a Chinese Han population

  2023cited by this paper
• Endomyocardial biopsy in the clinical context: current indications and challenging scenarios

  2022cited by this paper
• Deep Learning Facilitates Distinguishing Histologic Subtypes of Pulmonary Neuroendocrine Tumors on Digital Whole-Slide Images

  2022cited by this paper
• Single-cell transcriptomics provides insights into hypertrophic cardiomyopathy.

  2022cited by this paper
• Lack of NPR1 Increases Vascular Endothelial Adhesion through Induction of Integrin Beta 4

  2022cited by this paper
• Fibroblast growth factor receptor signaling in cardiomyocytes is protective in the acute phase following ischemia-reperfusion injury

  2022cited by this paper
• Ang II (Angiotensin II)–Induced FGFR1 (Fibroblast Growth Factor Receptor 1) Activation in Tubular Epithelial Cells Promotes Hypertensive Kidney Fibrosis and Injury

  2022cited by this paper
• Single-nucleus profiling of human dilated and hypertrophic cardiomyopathy

  2022cited by this paper
• Cardiac Fibrosis: Key Role of Integrins in Cardiac Homeostasis and Remodeling

  2021cited by this paper
• Cardiomyopathies: An Overview

  2021cited by this paper
• ERRγ enhances cardiac maturation with T-tubule formation in human iPSC-derived cardiomyocytes

  2021cited by this paper
• Generation of mature compact ventricular cardiomyocytes from human pluripotent stem cells

  2021cited by this paper
• Multiomics Analysis of Transcriptome, Epigenome, and Genome Uncovers Putative Mechanisms for Dilated Cardiomyopathy

  2021cited by this paper
• Progression of Myocardial Fibrosis in Nonischemic DCM and Association with Mortality and Heart Failure Outcomes.

  2021cited by this paper
• Inference and analysis of cell-cell communication using CellChat

  2020cited by this paper
• Deficiency of Cardiac Natriuretic Peptide Signaling Promotes Peripartum Cardiomyopathy-Like Remodeling in the Mouse Heart

  2020cited by this paper
• Meta-Analysis of Dilated Cardiomyopathy Using Cardiac RNA-Seq Transcriptomic Datasets

  2020cited by this paper
• FORT-1: Phase II/III Study of Rogaratinib Versus Chemotherapy in Patients With Locally Advanced or Metastatic Urothelial Carcinoma Selected Based on FGFR1/3 mRNA Expression

  2020cited by this paper
• Myocardial Gene Expression Signatures in Human Heart Failure with Preserved Ejection Fraction.

  2020cited by this paper
• Cardiac fibrosis.

  2020cited by this paper
• Genetic Ablation and Guanylyl Cyclase/Natriuretic Peptide Receptor-A: Impact on the Pathophysiology of Cardiovascular Dysfunction

  2019cited by this paper
• Quantification of histopathological findings using a novel image analysis platform

  2019cited by this paper
• Targeting Cardiac Fibrosis with Engineered T cells

  2019cited by this paper
• Dilated cardiomyopathy

  2019cited by this paper
• Erdafitinib in Locally Advanced or Metastatic Urothelial Carcinoma.

  2019cited by this paper
• Native T1 Mapping and Extracellular Volume Mapping for the Assessment of Diffuse Myocardial Fibrosis in Dilated Cardiomyopathy.

  2018cited by this paper
• Structure and function of the Nppa–Nppb cluster locus during heart development and disease

  2018cited by this paper
• Induction of Human Induced Pluripotent Stem Cells to Cardiomyocytes Using Embryoid Bodies.

  2018cited by this paper
• Distinct submembrane localisation compartmentalises cardiac NPR1 and NPR2 signalling to cGMP

  2018cited by this paper
• Transcriptome analysis of human heart failure reveals dysregulated cell adhesion in dilated cardiomyopathy and activated immune pathways in ischemic heart failure

  2018cited by this paper
• Myocardial fibrosis: biomedical research from bench to bedside

  2017cited by this paper
• Matrix Metalloproteinases in Myocardial Infarction and Heart Failure.

  2017cited by this paper
• Ankyrin Repeat Domain 1 Protein: A Functionally Pleiotropic Protein with Cardiac Biomarker Potential

  2017cited by this paper
• A randomized, open-label study of the efficacy and safety of AZD4547 monotherapy versus paclitaxel for the treatment of advanced gastric adenocarcinoma with FGFR2 polysomy or gene amplification

  2017cited by this paper
• The Diagnosis and Evaluation of Dilated Cardiomyopathy.

  2016cited by this paper
• Fibrosis of extracellular matrix is related to the duration of the disease but is unrelated to the dynamics of collagen metabolism in dilated cardiomyopathy

  2016cited by this paper
• Current Diagnostic and Treatment Strategies for Specific Dilated Cardiomyopathies: A Scientific Statement From the American Heart Association.

  2016cited by this paper
• Circulating Biomarkers of Myocardial Fibrosis: The Need for a Reappraisal.

  2015cited by this paper
• Quantification of myocardial fibrosis by digital image analysis and interactive stereology

  2014cited by this paper
• Fibroblast Growth Factor Receptor 1 Signaling in Adult Cardiomyocytes Increases Contractility and Results in a Hypertrophic Cardiomyopathy

  2013cited by this paper
• AZD4547: an orally bioavailable, potent, and selective inhibitor of the fibroblast growth factor receptor tyrosine kinase family.

  2012cited by this paper
• Cardiac fibroblasts, fibrosis and extracellular matrix remodeling in heart disease

  2012cited by this paper
• Follistatin-Like 3 Mediates Paracrine Fibroblast Activation by Cardiomyocytes

  2012cited by this paper
• Targeted disruption of Hspa4 gene leads to cardiac hypertrophy and fibrosis.

  2012cited by this paper
• Cardiac Myocyte-specific Ablation of Follistatin-like 3 Attenuates Stress-induced Myocardial Hypertrophy*

  2011cited by this paper
• Cyclic GMP signaling in cardiovascular pathophysiology and therapeutics.

  2009cited by this paper
• Enhanced activation of pro-inflammatory cytokines in mice lacking natriuretic peptide receptor-A.

  2007cited by this paper
• Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy.

  2006cited by this paper
• Circulating matrix metalloproteinase-2 but not matrix metalloproteinase-3, matrix metalloproteinase-9, or tissue inhibitor of metalloproteinase-1 predicts outcome in patients with congestive heart failure.

  2005cited by this paper
• Targeted deletion or pharmacological inhibition of MMP-2 prevents cardiac rupture after myocardial infarction in mice.

  2005cited by this paper

• PHLDA1 is a shared diagnostic and key mediator of inflammatory fibrosis in heart and kidney.

  2026cites this paper